163 related articles for article (PubMed ID: 7577949)
21. Lack of evidence for a role for the lipoxygenase pathway in increases in cytosolic calcium evoked by ADP and arachidonic acid in human platelets.
Vindlacheruvu RR; Rink TJ; Sage SO
FEBS Lett; 1991 Nov; 292(1-2):196-200. PubMed ID: 1959606
[TBL] [Abstract][Full Text] [Related]
22. N-(4-chlorophenyl)-N-hydroxy-N'-(3-chlorophenyl)urea, a general reducing agent for 5-, 12-, and 15-lipoxygenases and a substrate for their pseudoperoxidase activities.
Falgueyret JP; Desmarais S; Roy PJ; Riendeau D
Biochem Cell Biol; 1992; 70(3-4):228-36. PubMed ID: 1515123
[TBL] [Abstract][Full Text] [Related]
23. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
24. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells.
Lepley RA; Fitzpatrick FA
Arch Biochem Biophys; 1996 Jul; 331(1):141-4. PubMed ID: 8660693
[TBL] [Abstract][Full Text] [Related]
26. New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition.
Chiasson AI; Robichaud S; Ndongou Moutombi FJ; Hébert MPA; Mbarik M; Surette ME; Touaibia M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066378
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis.
La E; Kern JC; Atarod EB; Kehrer JP
Toxicol Lett; 2003 Mar; 138(3):193-203. PubMed ID: 12565196
[TBL] [Abstract][Full Text] [Related]
28. Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity.
Hill E; Maclouf J; Murphy RC; Henson PM
J Biol Chem; 1992 Nov; 267(31):22048-53. PubMed ID: 1429555
[TBL] [Abstract][Full Text] [Related]
29. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
30. Competitive inhibition of the 5-lipoxygenase-catalysed linoleate oxidation by arachidonic and 5-hydroperoxy-eicosatetraenoic acids.
Mirzoeva OK; Sud'ina GF; Pushkareva MA; Varfolomeev SD
FEBS Lett; 1995 Dec; 377(3):306-8. PubMed ID: 8549743
[TBL] [Abstract][Full Text] [Related]
31. Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction.
Riendeau D; Falgueyret JP; Guay J; Ueda N; Yamamoto S
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):287-92. PubMed ID: 2001245
[TBL] [Abstract][Full Text] [Related]
32. Effect of arachidonic acid on the L-type calcium current in frog cardiac myocytes.
Petit-Jacques J; Hartzell HC
J Physiol; 1996 May; 493 ( Pt 1)(Pt 1):67-81. PubMed ID: 8735695
[TBL] [Abstract][Full Text] [Related]
33. ATP binding in peptide synthetases: determination of contact sites of the adenine moiety by photoaffinity labeling of tyrocidine synthetase 1 with 2-azidoadenosine triphosphate.
Pavela-Vrancic M; Pfeifer E; van Liempt H; Schäfer HJ; von Döhren H; Kleinkauf H
Biochemistry; 1994 May; 33(20):6276-83. PubMed ID: 8193142
[TBL] [Abstract][Full Text] [Related]
34. Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation.
Du L; Zhang Z; Luo X; Chen K; Shen X; Jiang H
J Biochem; 2006 Apr; 139(4):715-23. PubMed ID: 16672272
[TBL] [Abstract][Full Text] [Related]
35. Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations.
Skorey KI; Gresser MJ
Biochemistry; 1998 Jun; 37(22):8027-34. PubMed ID: 9609696
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
Gupta N; Nicholson DW; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
[TBL] [Abstract][Full Text] [Related]
37. Central role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cells.
Ghosh J; Myers CE
Adv Exp Med Biol; 1999; 469():577-82. PubMed ID: 10667385
[No Abstract] [Full Text] [Related]
38. Mg2+ activates 5-lipoxygenase in vitro: dependency on concentrations of phosphatidylcholine and arachidonic acid.
Reddy KV; Hammarberg T; Rådmark O
Biochemistry; 2000 Feb; 39(7):1840-8. PubMed ID: 10677235
[TBL] [Abstract][Full Text] [Related]
39. Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts.
Stockton RA; Jacobson BS
Mol Biol Cell; 2001 Jul; 12(7):1937-56. PubMed ID: 11451994
[TBL] [Abstract][Full Text] [Related]
40. 2- and 8-azido photoaffinity probes. 2. Studies on the binding process of 2-5A synthetase by photosensitive ATP analogues.
Suhadolnik RJ; Li SW; Sobol RW; Haley BE
Biochemistry; 1988 Nov; 27(24):8846-51. PubMed ID: 2853970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
